Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

Fighting Addiction in New Jersey: Dr. Indra Cidambi Issues Statement to New Jersey Governor-Elect Phil Murphy
  • USA - English


News provided by

Center for Network Therapy

Jan 11, 2018, 09:15 ET

Share this article

Share toX

Share this article

Share toX

MIDDLESEX, N.J. (PRWEB) January 11, 2018 -- Governor-Elect Phil Murphy: You will be taking the reins of New Jersey from Governor Chris Christie in just a few weeks. You will inherit a state, just like large parts of America, ravaged by addiction to drugs that has left communities and families grappling with the fallout from loved ones entrapped by this disease. As per the Star-Ledger, “deaths from drug overdoses (in New Jersey) likely topped 2,000 in 2016, killing more people than guns, car accidents and suicides combined.”

I am on the frontlines of fighting this epidemic - I treat patients suffering from substance use disorders every day, as the Medical Director at Center for Network Therapy. While there are successes, often times, it can seem hopeless; individuals suffering from this chronic disease rotate through treatment facilities without getting a grip on recovery. With well over a decade of my career dedicated to helping people suffering from addiction, I have learned that individualized treatment to fit the patients’ needs that is integrated with his/her living environment is key. With right treatment, there is light at the end of the tunnel. I have faith that you will rise to the challenge and help make a dent in this epidemic. In my humble opinion, you should keep the following in mind in order to deliver better results and help save lives.

Support Innovative Treatment Modalities: When you cast an analytical eye at incumbent addiction treatment options, I am sure you will ask, “Is the traditional inpatient treatment model failing individuals with addiction issues?” It pains me to witness the current “go to” form of treatment – in-patient detoxification and rehab – failing people suffering from substance use disorders. However, I am happy to note that you plan to rein in excessive out-of-network costs. This will help keep people with addiction issues stay closer to home instead of going to “Florida” for resort-type “treatment.”

Extending that line of thinking, I believe the outpatient treatment model should be emphasized. It teaches individuals with addiction issues to stay sober in the home environment, as opposed to being isolated from it. I pioneered the use of Ambulatory (Outpatient) Detoxification in New Jersey at the Center for Network Therapy nearly five years ago and we have delivered results that are far superior to inpatient detoxification. The reasons for the higher success rate are individualized treatment, bringing the patient’s network into treatment and teaching the patient to stay sober in his/her home environment. I sincerely hope that you will examine this innovative model and embrace it, as it not only delivers higher efficacy, it also lowers costs significantly. The cost of sticking to the status quo treatment modalities in terms of human lives is just too great.

Advocate Decriminalization (Offers Dual Benefits): Just take a look at the data! As per the FBI, there were roughly 1.5 million arrests for drug law violations in 2015 and four out of five were for possession, not sales or manufacture. Decriminalization of drug possession related violations may offer the biggest bang for the buck because, according to the U.S. Department of Justice, more than 50% of the costs tied to illicit drug use are related to criminal justice and incarceration. It is time we utilize the ‘token economy’ modality of treatment that universally offers individuals a clean record upon successful completion of addiction treatment. This would cut criminal justice costs dramatically and also enable those in recovery to more easily re-integrate into the economy. Currently, I find many individuals in recovery are frustrated by their inability to re-enter the workforce due to charges on their record. It also acts as a trigger for relapse.

Focus on Prevention: You are right to highlight prevention as a first line of defnse. The best way to prevent drug addiction and overdose is to prevent people from abusing drugs in the first place. In 2015, 58% of overdose deaths involved prescription medication. To reverse this trend, not only should there be a vastly greater investment in educating the public about the addictive potential of some prescription medications, but also a push to allowing only physicians in certain specialties with a fuller understanding of the underlying disease requiring addictive medications to prescribe them. Another idea would be that the government mandate that every physician's office display educational posters that warn about the addictive potential of certain medications, such as opiates (used to treat pain), benzodiazepines (used to treat anxiety), and stimulants (used to treat Attention Deficit Hyperactivity Disorder). This approach will encourage patients to have an informed conversation with their physicians about limiting the use of addictive medications.

Recognize that Medication is not a Panacea: MAT (medication assisted treatment) does not mean utilizing medication alone as treatment. Medication needs to be used in conjunction with therapy to effect life style changes needed to stay on the path to sobriety.

In the recent past, an expanding class of medical professionals have been allowed to prescribe medication needed to treat addiction. There cannot be a bigger blunder than this. Even if overdose deaths dip in the near-term, it will likely prove to be the proverbial “calm before the storm.” It is well known in the addiction treatment community that ready availability of certain medications only leads to more indiscriminate use of drugs, as the user has medications on him/her to address withdrawal symptoms or, in certain cases, protect from overdose. The incentive to engage in wholesome treatment, that is desperately needed, is dramatically lowered. After all, if one has a heart condition, would it be in the patient’s best interest to obtain medications from any physician (who is not a cardiologist), nurse practitioner or physician assistant who has little knowledge of treating heart conditions? Then why so, for people with addiction issues? Is their life less valuable?

For more information on substance abuse dependency, addiction and treatment, please go to http://www.recoveryCNT.com.

About Dr. Indra Cidambi
Indra Cidambi, M.D., Medical Director, Center for Network Therapy, is recognized as a leading expert and pioneer in the field of Addiction Medicine. Under her leadership the Center for Network Therapy started New Jersey’s first state licensed Ambulatory (Outpatient) Detoxification program for all substances over four years ago. Dr. Cidambi is Board Certified in General Psychiatry and double Board Certified in Addiction Medicine (ABAM, ABPN). She is fluent in five languages, including Russian. She is the Vice President of the New Jersey chapter of ASAM.

About Center for Network Therapy
Center for Network Therapy (CNT) was the first facility in New Jersey to be licensed to provide Ambulatory (Outpatient) Detoxification Services for all substances of abuse – alcohol, anesthetics, benzodiazepines, opiates and other substances of abuse. Led by a Board Certified Addiction Psychiatrist, Indra Cidambi, M.D., experienced physicians and nurses closely monitor each patient’s progress. With CNT’s superior client care and high quality treatment, Dr. Cidambi and her clinical team have successfully detoxed over 1200 patients in four years.

# # #

Marisa Amador, Center for Network Therapy, +1 212.805.3029, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.